What are the profiles of both users and non-users of car sharing in European cities regarding their travel patterns and psychological aspects? Two subsamples (1519 users and 3695 non-users of car sharing) participated in a survey, translated into seven languages, with 36 questions regarding attitudes towards car sharing, the environment, political orientation, personal norms, frequency of use of different transport modes and transport mode choice for different travel purposes. Through a hierarchical cluster analysis, five distinct mobility styles were identified, with no a priori restriction of the number of clusters. The mobility styles were further characterised by sociodemographic variables and by the motives for making use of car sharing. This paper discusses the implications of research based decision-making and urban planning in a way that guarantees long-term human and environmental security.

No abstract

No abstract

Glucocorticoids (GCs) are commonly used as therapeutic agents for immune-mediated diseases and leukemia. However, considerable inter-individual differences in efficacy have been reported. Several reports indicate that the inhibitor of mTOR rapamycin can reverse GC resistance, but the molecular mechanism involved in this synergistic effect has not been fully defined. In this context, we explored the differential miRNA expression in a GC-resistant CCRF-CEM cell line after treatment with rapamycin alone or in co-treatment with methylprednisolone (MP). The expression analysis identified 70, 99 and 96 miRNAs that were differentially expressed after treatment with MP, rapamycin and their combination compared to non-treated controls, respectively. Two pathways were exclusively altered as a result of the co-treatment: the MAPK and ErbB pathways. We validated the only miRNA upregulated specifically by the co-treatment associated with the MAPK signaling, miR-331-3p. Looking for miR-331-3p targets, MAP2K7, an essential component of the JNK/MAPK pathway, was identified. Interestingly, MAP2K7 expression was downregulated during the co-treatment, causing a decrease in terms of JNK activity. miR-331-3p in mimic-transfected cells led to a significant decrease in MAP2K7 levels and promoted the reversion of GC resistance in vitro. Interestingly, miR-331-3p expression was also associated with GC-resistance in patient leukemia cells taken at diagnosis. The combination of rapamycin with MP restores GC effectiveness through the regulation of different miRNAs, suggesting the important role of these pharmacoepigenetic factors in GC response.

No abstract